How does continuous glucose monitoring improve glycemic control in adults with type 2 diabetes on basal insulin?
A 3-month MOBILE analysis finds CGM lowers HbA1c more than fingerstick monitoring and reduces hypoglycaemia in basal-insulin-treated type 2 diabetes, with benefits within a week. PICO summary and commentary.
